Actinium

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Name
Actinium
Accession Number
DB12860
Type
Small Molecule
Groups
Investigational
Description

Actinium has been investigated for the treatment of Breast Cancer and Pulmonary Disease, Chronic Obstructive.

Structure
Thumb
Synonyms
  • Ac
  • actinio
Categories
UNII
NIK1K0956U
CAS number
7440-34-8
Weight
Average: 227.0
Monoisotopic: 227.0
Chemical Formula
Ac
InChI Key
QQINRWTZWGJFDB-UHFFFAOYSA-N
InChI
InChI=1S/Ac
IUPAC Name
actinium
SMILES
[Ac]

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
Not Available
Food Interactions
Not Available

References

General References
Not Available
External Links
PubChem Compound
23965
PubChem Substance
347829019
ChemSpider
22404
ChEBI
33337
Wikipedia
Actinium

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
2Active Not RecruitingOtherCancer, Breast / Locally Advanced Malignant Neoplasm1
2CompletedTreatmentCancer, Breast2
2RecruitingTreatmentCancer, Breast1
3CompletedPreventionCancer, Breast1
3CompletedTreatmentCancer, Breast / Neoplasms Metastasis1
Not AvailableCompletedNot AvailableChronic Obstructive Pulmonary Disease (COPD)1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility0.0 mg/mLALOGPS
logP-1.3ALOGPS
logP0ChemAxon
logS1.08ALOGPS
Physiological Charge0ChemAxon
Hydrogen Acceptor Count0ChemAxon
Hydrogen Donor Count0ChemAxon
Polar Surface Area0 Å2ChemAxon
Rotatable Bond Count0ChemAxon
Refractivity0 m3·mol-1ChemAxon
Polarizability1.78 Å3ChemAxon
Number of Rings0ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleYesChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot Available

Taxonomy

Description
This compound belongs to the class of inorganic compounds known as homogeneous actinide compounds. These are inorganic compounds containing only metal atoms,with the largest atom being a transition metal atom.
Kingdom
Inorganic compounds
Super Class
Homogeneous metal compounds
Class
Homogeneous actinide compounds
Sub Class
Not Available
Direct Parent
Homogeneous actinide compounds
Alternative Parents
Not Available
Substituents
Homogeneous actinide
Molecular Framework
Not Available
External Descriptors
scandium group element atom, actinoid atom, f-block element atom (CHEBI:33337)

Drug created on October 20, 2016 18:46 / Updated on June 04, 2019 07:43